PEAK6 Investments’s Novo Nordisk NVO Stock Holding History

PEAK6 Investments’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$7.88M	Buy	+66,149	New	+$8.82M	0.02%	690
2023 Q4	–	Sell	-5,314	Closed	-$526K	–	4651
2023 Q3	$483K	Buy	+5,314	New	+$468K	﹤0.01%	2416
2022 Q4	–	Sell	-52,634	Closed	-$3.09M	–	4986
2022 Q3	$2.62M	Sell	52,634 -55,098	-51%	-$2.95M	0.01%	1329
2022 Q2	$6M	Buy	107,732 +40	+0%	+$2.22K	0.01%	1235
2022 Q1	$5.98M	Buy	+107,692	New	+$5.53M	0.01%	982
2021 Q4	–	Sell	-10,358	Closed	-$497K	–	5597
2021 Q3	$497K	Sell	10,358 -91,648	-90%	-$4.43M	﹤0.01%	3264
2021 Q2	$4.27M	Buy	102,006 +25,734	+34%	+$998K	0.01%	1231
2021 Q1	$2.57M	Sell	76,272 -13,036	-15%	-$464K	0.01%	1630
2020 Q4	$3.12M	Buy	+89,308	New	+$3.09M	0.01%	1470
2020 Q1	–	Sell	-404	Closed	-$12K	–	4413
2019 Q4	$12K	Buy	+404	New	+$11.2K	﹤0.01%	3208
2019 Q3	–	Sell	-29,438	Closed	-$744K	–	4113
2019 Q2	$751K	Buy	29,438 +23,648	+408%	+$584K	0.01%	1990
2019 Q1	$151K	Buy	+5,790	New	+$142K	﹤0.01%	3074

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PEAK6 Investments's NVO Position: Q3 2024 in Review

PEAK6 Investments opened a new position in Novo Nordisk (NVO) in Q3 2024: 66,149 shares worth $7.88M. The stake represents 0.02% of the portfolio and ranks #690 among its holdings. This is a return to the name: PEAK6 Investments previously reported a position in NVO as recently as Q3 2023.

PEAK6 Investments first reported a position in NVO in Q1 2019 and has held it in 12 quarters since. 1,784 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

PEAK6 Investments held 66,149 shares of Novo Nordisk worth $7.88M as of Q3 2024.
Novo Nordisk was a new PEAK6 Investments position in Q3 2024.
Novo Nordisk made up 0.02% of PEAK6 Investments's portfolio in Q3 2024, its #690 holding.
PEAK6 Investments first reported a position in Novo Nordisk in Q1 2019 and has held it in 12 quarters since.
1,784 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.